Health Condition 1: N394- Other specified urinary incontinence
Conditions
Interventions
Intervention1: Remote Pilates with Pelvic floor muscle training: Remote Pilates and PFMT in Group A Sessions will be conducted under the supervision of a licensed physiotherapist and are conducted liv
Sponsors
Isha Tyagi
Eligibility
Inclusion criteria
Inclusion criteria: Female participants aged 30 to 45 years Persistent urinary leakage symptoms as seen by pre-screening Incontinence Questionnaire Possess the cognitive ability to comprehend, follow, and execute the therapeutic instructions effectively. Leakage on the 3-h pad test of 1 to 2 g (mild) or 2 to10 g (moderate) as seen during in person screening Must have access to a stable internet connection and a functional smart device (smartphone, tablet, or computer) to participate in remote pilates sessions. Demonstrate willingness to engage in the full eight-week intervention program, maintaining three structured sessions per week, along with scheduled follow-up evaluations. Voluntarily provide informed written consent. Capable of communicating in english language.
Exclusion criteria
Exclusion criteria: Pregnant or women in the early postpartum period (less than six months postpartum) Women with pelvic organ prolapse (grade II or above), diagnosed by Gyanecologists Individuals presenting with neurological impairments (e.g., stroke, multiple sclerosis, spinal cord injury) impacting voluntary bladder or pelvic floor control. Cases diagnosed solely with urge urinary incontinence, lacking a stress or mixed component. Concurrent participation in other pelvic health therapies, pharmacological treatments for urinary incontinence, or on oestrogen treatment for other conditions or any form of physiotherapy targeting pelvic function during the study period. Individuals with uncontrolled systemic illnesses (cardiac, metabolic, respiratory) contraindicating moderate-intensity exercise participation. Cognitive or psychological disorders (e.g., severe anxiety, major depressive disorder) that may compromise adherence and participation in therapy sessions. Reluctance or inability to fully commit to the study duration, intervention schedule, or follow-up assessments.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in urinary leakage.Timepoint: Baseline and post intervention | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement in quality of life.Timepoint: Baseline and post intervention | — |
Countries
India
Contacts
Public ContactDr Ankita Sharma
Amity Institute of health allied sciences
Outcome results
None listed